This group shows a lower BMI than SIRD and MOD, severe insulin resistance, a high level of insulin secretion, good metabolic control, a high risk of developing metabolic-associated fatty liver disease (MAFLD), and a similar risk to SIRD of CKD, although lower than MOD (45, 58). This evidence concerns the gene INS and fatty liver disease.